Edurant

GlaxoSmithKline GSK House in Brentford UK

NICE says yes to GSK's Cabenuva, new option for HIV patients

GSK’s long-acting HIV treatment Cabenuva has been approved by NICE, giving people the option of switching from daily pills to six injections per year.

Kevin Dunleavy Nov 18, 2021 2:25am

GSK's ViiV touts 2-month, dual-drug HIV win

Aug 22, 2019 11:48am

J&J-backed AIDS film picked up by Verizon Media

May 10, 2019 10:15am

GSK gambles against Gilead with risky bet on 2-drug HIV combos

Sep 6, 2016 10:06pm